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Abstract
Introduction: Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for
Alzheimer’s disease and related dementias (ADRDs), affecting many different pathways that lead to cognitive decline. Exercise is one of the most widely proposed prevention and intervention strategies to mitigate risk and symptomology of ADRDs. Importantly, exercise and APOE ε4 affect similar processes in the body and brain. While both
APOE ε4 and exercise have been studied extensively, their interactive effects are not
well understood.
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Methods: To address this, male and female APOE ε3/ε3, APOE ε3/ε4, and APOE ε4/ε4
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markers of risk for dementia such as weight, body composition, circulating cholesterol

mice ran voluntarily from wean (1 month) to midlife (12 months). Longitudinal and
cross-sectional phenotyping were performed on the periphery and the brain, assessing
composition, murine daily activities, energy expenditure, and cortical and hippocampal
transcriptional profiling.
Results: Data revealed chronic running decreased age-dependent weight gain, lean
and fat mass, and serum low-density lipoprotein concentration dependent on APOE
genotype. Additionally, murine daily activities and energy expenditure were significantly influenced by an interaction between APOE genotype and running in both sexes.
Transcriptional profiling of the cortex and hippocampus predicted that APOE genotype and running interact to affect numerous biological processes including vascular
integrity, synaptic/neuronal health, cell motility, and mitochondrial metabolism, in a
sex-specific manner.
Discussion: These data in humanized mouse models provide compelling evidence that
APOE genotype should be considered for population-based strategies that incorporate
exercise to prevent ADRDs and other APOE-relevant diseases.
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BACKGROUND
RESEARCH IN CONTEXT

Aging and apolipoprotein E (APOE) ε4 are the strongest risk factors

1. Systematic Review: The authors have surveyed literature

for Alzheimer’s disease and related dementias (ADRDs).1 With APOE

through traditional methods, conference presentations,

ε4 implicated in unfavorable systemic changes such as high body

and other online platforms (Alzforum.org). While exercise

mass index, dysregulated cholesterol concentrations, and aberrant

is often studied after dementia onset in humans, studies

metabolism, as well as deficits in cerebral health such as changes in

of exercise in dementia mouse models have had signifi-

cerebral metabolism, cerebrovasculature, and neuronal health, the

cant limitations.

APOE ε4 allele has been targeted to help reverse these risks.2–7 The

2. Interpretation: Our findings support that apolipopro-

cerebral changes caused by APOE ε4 emerge in humans at early ages

tein E (APOE) ε4 dosage affects the body and brain and

and can worsen with advancing age.8–12 Further, the impact of APOE

interacts with running in a unique pattern that differs

ε4 dosage (such as in the APOE ε3/ε4 vs. APOE ε4/ε4 genotype) on

between males and females. These results should be con-

peripheral and brain health during aging is understudied. Targeting

sidered during the development of strategies to prevent

APOE ε4 through pharmacological interventions has resulted in both

or reduce risk of human dementia through exercise.

beneficial and damaging outcomes meaning therapies targeting

3. Future Directions: This work highlights the interac-

APOE-dependent pathways will likely need to be tailored to specific

tions between APOE ε4 and running in male and female

mechanisms.13–16

mice; however, interrogation of specific mechanisms

While pharmacological interventions are still being investigated,

is still necessary. While here we studied early aging

others have turned to non-pharmacological interventions to reduce
risk for ADRDs, such as

exercise.13,17

(birth to midlife), future studies can determine the

Studies in mice show ben-

effects of advanced aging, APOE ε4 dosage, and run-

efits of exercise to peripheral health, as well as improvements to

ning. Finally, human trials would be useful to vali-

cognitive function.18–27 Though the cognitive changes due to exer-

date these APOE ε4 genotype effects on the body and

cise have been controversial, with human studies showing either no

brain.

change or improvements with exercise, it is widely accepted that exercise affects the body in a generally positive manner (i.e., decreasing
weight/fat mass, improving metabolism and circulation, and elevating
mood).19,28–33 While understanding the effect of exercise on neuronal
health is critical, other compartments of the brain are largely neglected.
It is essential to understand how exercise affects all mechanisms that
pertain to ADRD risk, such as metabolism and vascular health.
It is unknown if the detrimental effects associated with APOE ε4 can
be mitigated by exercise, or conversely, whether the effects of exercise are impacted by APOE ε4 genotype. Studies in previous models of
APOE mice are usually completed in one sex, with some, but not all,
studies showing age-related cognitive deficits. Other mouse studies
show worsened ADRD pathology in APOE ε4 mice, begging the question whether APOE ε4’s effects on ADRD can be influenced by exercise.
Studies on exercise in humans are performed later in life after symptom

kept in a 12/12-hour light/dark cycle (06:00–18:00 light) and fed ad
libitum 6% kcal fat standard mouse chow. Experimental cohorts were
generated by intercrossing male and female APOE ε3/ε4 mice to create APOE ε3/ε3, APOE ε3/ε4, and APOE ε4/ε4 male and female littermate controls. As with previous studies, APOE ε3/ε3 mice served as
the control genotype in these studies to standardize any human APOE
insertion differences.3,35–37 Animals were divided as evenly as possible per litter into running and sedentary cohorts. All experiments were
approved by the Institutional Animal Care and Use Committee (IACUC)
at The Jackson Laboratory.

onset, typically measuring improvements to activities of daily living and
quality of life. While important, it is necessary to understand whether
running can influence risk factors for dementia before symptomology.
We evaluated the systemic and cerebral effects of running across APOE
ε3/ε3, APOE ε3/ε4, and APOE ε4/ε4 litter-matched mice during early
aging. We show that chronic running affects multiple ADRD-relevant
phenotypes in both the periphery and the brain, but these effects are
both APOE genotype- and sex-specific.

2.2

Exercise by voluntary running

Mice were group-housed into two or three per cage and given 24-hour
access to an unlocked (running) or locked (sedentary) running wheel
(Innovive). At 5 months, mice were singly housed for the remaining
duration of the experiment to enable data to be collected on individual mice. Mice were not returned to group housing to prevent fighting.
At 6 and 11 months, running mice were tracked for number of rota-

2

METHODS

tions per minute during the dark cycle when they are most active using
trackable running wheels (Med Associates, Inc.). Nights during which

2.1

Mouse husbandry

fewer than 700 minutes of data were tracked were considered incomplete and excluded from analysis. For each mouse, sum of rotations per

Novel APOE mouse strains were created on C57BL/6J (B6) and main-

night (n = 7 + nights tracked) was calculated and then averaged across

tained at The Jackson Laboratory as previously described.34

all nights.

Mice were
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2.3
Harvesting, tissue preparation, plasma
collection

RNA sequencing, and seq quality control were performed as described
previously.34,38 Genes were then filtered by (1) removing all genes that
did not vary in expression (gene count change across all samples was

All mice were euthanized by intraperitoneal injection of a lethal dose

0) and (2) removing all genes that did not have at least five reads in

of ketamine (100 mg/ml)/xylazine (20 mg/ml). Mice were perfused

50% of the samples. Remaining genes (20,641) were normalized using

intracardially with 1X phosphate buffered saline. Brains were carefully

DEseq2.45 Principal component analysis (PCA) on the variance stabi-

dissected, hemisected sagittally, and one half was then snap frozen

lized data (vst) identified outliers. To allow for the evaluation of APOE

on solid CO2 for later dissection and RNA sequencing. At timepoints

ε4 allele dosage, each linear model included two genotype compar-

throughout the experiment, blood plasma was collected via cheek

isons: (1) APOE ε3/ε4 to APOE ε3/ε3 and (2) APOE ε4/ε4 to APOE ε3/ε3.

bleed. Blood was carefully collected in K2 EDTA (1.0 mg) microtainer

Linear models were run separately for (1) cortex – female, (2) cor-

tubes (BD Biosciences), allowed to sit at room temperature for at least

tex – male, (3) hippocampus – female, and (4) hippocampus – male. β-

30 minutes, and then centrifuged at 21◦ C for 10 minutes at 5031 g.

estimates were obtained for all four linear models that evaluated the

Plasma was carefully collected and stored at –20◦ C. At the harvest

main effects of APOE genotype (APOE ε3/ε4, APOE ε4/ε4, ref: APOE

timepoint (12 months), blood was collected in K2 EDTA (1.0 mg)

ε3/ε3) and running (run, ref: sed), as well as the interaction between

microtainer tubes (BD Biosciences) through cardiac puncture. Plasma

APOE genotype and running (APOE ε3/ε4:Run, APOE ε4/ε4:Run). For

total cholesterol (mg/dL), direct low-density lipoprotein (LDL; mg/dL),

each linear model, gseGO from the clusterProfiler package was run on

and high-density lipoprotein (HDL; mg/dL) concentrations were

genes significant for each factor. Gene set enrichment analysis (GSEA)

characterized on the Beckman Coulter AU680 chemistry analyzer. All

was used to determine Gene Ontology (GO) terms for the genes sig-

samples were profiled at the same time at the end of the experiment to

nificant for the main (running, APOE ε3/ε4, APOE ε4/ε4) and interact-

avoid batch effects.

ing factors (APOE ε3/ε4:Run and APOE ε4/ε4:Run). Normalized enrichment scores (NES) from GSEA were used to identify terms that were
positively or negatively associated with each factor. GO terms were

2.4

Nuclear magnetic resonance imaging

ordered based on the NES. Terms with a positive NES had more genes
higher on the ranked list (i.e., more positive β values) and the terms

Each cohort was subjected to nuclear magnetic resonance (NMR)

with a negative NES containing more genes lower on the ranked list

imaging at 6 and 11 months (female: n = 9–15), male: n = 11–15). NMR

(i.e., more negative β values). Enriched GO terms had overlapping bio-

was performed as previously described.38 Weight was measured, and

logical functions that we termed “vascular integrity,” “cellular motility,”

mice were briefly placed into a Plexiglas tube 2.5 in. by 8 in., which was

“immune system response,” “mitochondrial metabolism,” and “synap-

then subjected to NMR (EchoMRI). Magnetic field was measured by

tic/neuronal health.” The top 20 most positive and negative GO terms

a 5-gauss magnet. Measurements included weight, lean muscle mass,

were visualized for the cortex and hippocampus for both females and

and fat mass, as well as fat percentage ([fat/body weight] × 100).

males (Figures S10–S24 in supporting information).

2.5
Murine daily activities and indirect
calorimetry

2.7

After NMR measurements (female: n = 9–11 per genotype/activity,
male: n = 9–12 per genotype/activity), mice were measured for energy
balance through indirect calorimetry measurement cages (Sable
Promethion). Briefly, these specialized cages continuously measure

For running comparisons within sex and age, a one-way analysis of
variance (ANOVA) with Tukey’s multiple comparison was performed.
To determine age-related decline a two-sided paired t-test was performed.
For all weights, body composition analysis, murine daily activities,

food and water intake, general activity (pedometers), wheel running
behavior, energy expenditure (kcal/hr), and respiratory quotient (RQ).
Measurements are collected for 5 days in 5-minute interval bins. The
RQ is a ratio of the volume of carbon dioxide (CO2 ) released over the
volume of oxygen (O2 ) absorbed. RQ has been widely used in humans

Statistical analysis

and energy expenditure, a two-way ANOVA for APOE genotype, activity, and the interaction between APOE genotype and activity was calculated. Bonferroni post hoc corrections were calculated and significance
within genotype (the effect of running per genotype) was visualized.

and mice as a tool to determine the starting substrate for energy
metabolism (carbohydrate RQ ≈1, protein RQ ≈0.8, fat RQ ≈0.7, anaerobic respiration RQ ≈0, and multiple energy sources RQ ≈0.8).39–44

2.6

RNA sequencing, linear modeling, and GSEA

3

RESULTS

3.1
APOE genotype did not affect voluntary
running from young to midlife

We performed RNA sequencing on six brains per group (sex/

To determine the effects of one APOE ε4 allele to two APOE ε4 alle-

genotype/activity) at 12 months. RNA extraction, library construction,

les, we compared the APOE ε3/ε4 or APOE ε4/ε4 genotypes to the
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control, APOE ε3/ε3 genotype (Figure 1A). Previous studies have shown

Collectively, these data demonstrate that weight, body composi-

that females run more than males; therefore, we assessed the sexes

tion, and cholesterol levels, commonly used markers of healthy aging,

separately.38 There was no difference in voluntary running during the

are significantly affected by voluntary running, but the effects are

dark cycle across APOE genotypes; however, there was expected varia-

dependent upon both sex and APOE genotype.

tion between individual mice within the APOE genotypes (Figure 1B,C;
Figures S1–S2 in supporting information). There was an age-dependent
decrease in voluntary running from 6 to 11 months; however, there was
no difference between APOE genotypes (Figure 1D–G). These findings

3.3
Running affects murine daily activities in an
APOE genotype- and sex-specific manner

show that running is not a variable between the APOE genotypes, and
therefore not a confound in subsequent analyses.

In humans, prior to more severe cognitive decline in ADRDs, activities of daily living (i.e., sleep, general movement, feeding) are often
disrupted.53–55 To evaluate murine daily activities in mice, we mea-

3.2
APOE genotype and running interact in a
sex-specific manner to modulate general markers of
healthy aging

sured feeding and walking behavior (pedometers) across four dark
cycles (active/awake period), and three light cycles (inactive/sleep
period) at 11 months. Feeding behavior revealed significant changes
in the dark cycle, but not in the light cycle for both sexes. In females,

Weight, body composition (e.g., lean mass, fat mass, and fat percent-

running mice consumed more food than sedentary mice during the

age) and cholesterol levels are commonly used as a general proxy

dark cycle across all APOE genotypes (Figure 3A–C; Figure S7 in

humans.46–48

These biometrics are typically measured

supporting information). However, in males, there was an interaction

at routine physicals and are considered indicative of general health

between APOE genotype and running during the dark cycle (Figure

status, and markers for obesity, cardiovascular disruption, and lipid

3D–F). In sedentary mice, male APOE ε3/ε4 ate more than APOE

dysregulation.49–52 We examined whether running affected weight,

ε3/ε3 and APOE ε4/ε4. This pattern was not apparent in running mice,

body composition, and cholesterol across APOE genotypes. Monthly

suggesting running mitigates the APOE genotype differences observed

weights (from 1 to 12 months) revealed an expected age-dependent

in sedentary mice (Figure 3D; Figure S7).

for health in

weight gain in sedentary mice that was significantly attenuated by

We next determined whether movement in the home cage was

running (Figure 2A–F; Figure S3A–D in supporting information). In

affected by APOE genotype and/or running by measuring walking (Ped

females, but not males, the APOE ε4/ε4 genotype caused a greater

meters; see Methods). Female sedentary mice showed an APOE ε4

running-based attenuation in weight gain compared to APOE ε3/ε3 and

dose-dependent increase in Ped meters that was attenuated by run-

APOE ε3/ε4. These results suggest that the beneficial effects of running

ning (Figure 3G,H; Figure S7). During the light cycle only APOE ε4/ε4

on weight loss are APOE genotype-dependent in females only.

females showed a significant reduction in Ped meters compared to

Overall, running mice had a lower fat composition compared to

their sedentary counterparts (Figure 3I; Figure S7). In male mice, both

sedentary mice for both sexes at 6 and 11 months (Figures S4,5 in

APOE genotype and running interacted to alter Ped meters during both

supporting information). In females, only APOE ε4/ε4 mice showed

the dark and light cycle; however, running more strikingly increased

a significant attenuation of fat mass and fat percentage in running

cumulative Ped meters of APOE ε4/ε4 mice compared to the other

compared to sedentary mice (Figure 2G–I; Figure S3E–G). There

APOE genotypes (Figure 3K,L; Figure S7).

were no APOE genotype differences in male mice; however, there

These results show that APOE genotype modulates the effects of

was an effect of running on lean and fat mass. This effect was most

running on natural home cage behaviors such as feeding and general

pronounced in APOE ε3/ε4 male mice, with running attenuating lean

movement, considered equivalent to activities of daily living in humans.

and fat mass (Figure 2J–L; Figure S3H–J). Running attenuated the
age-related increase in lean and fat mass across all genotypes and
sexes. However, there was a pronounced reduction of age-related
fat mass accumulation in female APOE ε4/ε4 running mice. Also, male

3.4
APOE genotype affects running-dependent
increase in energy expenditure during the dark cycle

APOE ε3/ε4 running mice showed the greatest reduction in age-related
lean and fat mass accumulation.

Previous studies in humans demonstrated APOE genotype affects

No effect of running or APOE genotype was determined for total

metabolism on a cellular, regional, and organismal level.37,56 To

cholesterol or HDL concentration at 12 months (Figure S6 in support-

determine whether running and APOE genotype affect metabolic

ing information). There was a significant sex-specific effect of APOE

processes, energy expenditure (kcal/hr) was measured at 11 months.

genotype on LDL concentration in the plasma. In running females,

In female sedentary mice, energy expenditure showed an APOE ε4

LDL concentrations decreased in an APOE ε4 dose-dependent manner

dose-dependent increase during the dark cycle. In general, running

(Figure S6H). Conversely, in running males, LDL concentrations were

resulted in significantly higher energy expenditure in the dark cycle in

significantly lower than sedentary mice (Figure S6K). Cholesterol

male and female mice. However, this effect was not observed in male

composition in running mice did not correlate with running distance

APOE ε3/ε4 mice (Figure 4A–C; Figure S8 in supporting information).

for both sexes (Figure S6C,F,I,L,O,R).

This suggests the APOE ε3/ε4 genotype attenuates the effects of

5 of 14

FOLEY ET AL .

(A)

(B)

(C)

(D)

(E)

(F)

(G)

F I G U R E 1 Voluntary chronic running to midlife is not different between apolipoprotein E (APOE) genotypes. A, Schematic of the voluntary
running paradigm in which APOE ε3/ε3, APOE ε3/ε4, and APOE ε4/ε4 male and female mice were introduced to a locked (control – sedentary) or
unlocked (treatment – running) running wheel at 1 month until 12 months (midlife). Longitudinal, advanced, and post mortem phenotyping is
indicated. B-C, No difference in running (average rotations across multiple consecutive nights) between APOE genotypes at both 6 and 11 months
in female (B) or male (C) mice (n = 10–15). D-G, Average rotations per mouse at 6 and 12 months showed an age-dependent decrease for both
females (D) and males (F); however, the change over time was not significantly different between genotypes (E,G) (n = 10–15). Data presented as
mean ± standard deviation, one-way analysis of variance with Tukey’s multiple comparison performed for B,C,E,G. Two-sided paired t-test
performed for D,F. *P < .05, **P < .01

6 of 14

FOLEY ET AL .

(A)

(C)

(E)

(B)

(D)

(F)

(G)

(H)

(I)

(J)

(K)

(L)

F I G U R E 2 Running attenuated age-dependent weight gain and fat accumulation across apolipoprotein E (APOE) genotypes. A-B, Expected
age-dependent weight gain from 1 to 12 months in females (A, n = 9–15) and males (B, n = 11–15). C-D, Running mice weighed significantly less at
12 months in both females (C) and males (D). E-F, Running significantly attenuated age-dependent weight gain (the difference in body weight from
1 to 12 months) in both females (E) and males (F). G-I, Significant effect of running on the change in lean mass (G), fat mass (H), and fat percentage
(I) between 6 and 11 months, with an overall reduction in running mice compared to sedentary mice across all APOE genotypes in females. J-L,
Running had a significant reduction on the change in lean mass (J) and fat mass (K) between 6 and 11 months, but no change in fat percentage (L) in
male mice. Data presented as mean ± standard error of the mean, two-way analysis of variance performed for APOE genotype (significant marked
above “Sed” column, indicating an effect of APOE genotype), Running (significance marked above “Run” column, indicating an effect of running), and
the interaction between APOE genotype:Running (significance marked to the right of the graph). Bonferroni’s multiple comparisons performed for
within-genotype running effects (significance marked in smaller stars directly to the right of the run column, within graph limits, in the color of the
genotype). *P < .05, **P < .01, ***P < .001, ****P < .0001
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(A)

(B)

(C)

(D)

(E)

(F)

(G)

(H)

(I)

(J)

(K)

(L)

F I G U R E 3 Murine daily activities are influenced by apolipoprotein E (APOE) genotype and running. A,D, Cumulative food consumed per gram
for female (A, n = 9–11) and male (D, n = 9–12) mice across four dark cycles and three light cycles. B-C, Running significantly increased food
consumed during the dark cycle (B), but not the light cycle (C) in female mice. E-F, APOE genotype and APOE genotype:running interaction affected
food consumption in males during the dark cycle (E), but no effect was seen during the light cycle (F). G,J, General movement (cumulative ped
meters) for female (G) and male (J) mice across four dark cycles and three light cycles. H-I, APOE genotype, running, and APOE genotype:running
interaction all significantly affected ped meters during the dark cycle (H) with running decreasing ped meters differently across the genotypes.
Only APOE genotype was significant during light cycle (I) in female mice. K-L, APOE genotye:Running interaction significantly affected ped meters
in males, with APOE ε4/ε4 showing increased ped meters during the dark cycle (K), as well as the light cycle (L). There was also an APOE genotype
effect (L). Solid lines indicate Run mice, dashed lines indicate Sed mice (A,D,G,J). Data presented as mean ± standard error of the mean, two-way
analysisof variance performed for APOE genotype (significant marked above “Sed” column, indicating an effect of APOE genotype), running
(significance marked above “Run” column, indicating an effect of running), and APOE genotype:running interaction (significance marked in to the
right of the graph). Bonferroni’s multiple comparisons performed for within-genotype running effects (significance marked in smaller stars directly
to the right of the run column, within graph limits, in the color of the genotype). *P < .05, **P < .01, ***P < .001, ****P < .0001
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(A)

(B)

(D)

(C)

(G)

(H)

(E)

(F)

(J)

(I)

(K)

(L)

F I G U R E 4 Running influences energy expenditure differently between females and male apolipoprotein E (APOE) mice. A-C, Energy
expenditure (kcal/hr) across four dark cycles and three light cycles for female mice (n = 9–11). Energy expenditure (kcal/hr) significantly affected
by APOE gentoype:running, and running during the dark cycle (B), with an increase in energy expenditure in running mice. APOE genotype:running,
APOE genotype, and running all influenced light cycle energy expenditure (C), with APOE ε3/ε3 increasing with running while APOE ε3/ε4 and APOE
ε4/ε4 decreased energy expenditure with running. D-F, Energy expenditure (kcal/hr) across four dark cycles and three light cycles for male mice
(n = 9–12). E, APOE genotype:running, APOE genotype, and running all affected dark cycle energy expenditure in male mice. F, APOE
genotype:running and running showed an overall decrease in energy expenditure in running male mice. G-I, Respiratory quotient (RQ) across four
dark cycles and three light cycles for female mice (G). APOE genotype:running significantly affected RQ during the dark cycle for female mice (H).
APOE genotype and running significantly affected RQ during the light cycle for female mice (I). J-L, RQ across four dark cycles and three light cycles
for male mice (J). APOE genotype:running, APOE genotype, and running all significantly affected RQ during the dark cycle in male mice (K). APOE
genotype:running significantly affected RQ during the light cycle (L). Solid lines indicate Run mice, dashed lines indicate Sed mice (A,D,G,J). Data
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running in a sexually dimorphic manner. During the light cycle, all

4

DISCUSSION

genotypes showed decreased energy expenditure with running; except
for female APOE ε3/ε3 mice that showed an increase (Figure 4D–F;

Exercise is generally considered to have beneficial effects, but our

Figure S8). Subtle but significant changes in substrate usage (based

results show APOE genotype impacts the effects of running. Signifi-

on RQ; see Methods) were also determined across groups in both

cant interactions between APOE genotype and running were observed

the light and dark cycle (Figure 4G–L; Figure S8). Significant changes

across body weight, body composition, murine daily activities, sys-

were small; however, they may worsen with more advancing age

temic metabolism, and cortical and hippocampal gene expression. As

(Figure 4H–L; Figure S8). These results highlight that APOE genotype

with previous studies, to enable genotype comparisons between litter-

and running affect energy expenditure; however, changes in starting

mates, APOE ε3/ε3 were considered controls in all comparisons.3,35–37

energy substrate usage were minute (Figure 4A–F).

This was because APOE ε3 is considered the neutral allele in human
studies, although this design meant comparisons between human APOE
and mouse Apoe could not be made. Male and female mice were eval-

3.5
APOE genotype causes subtle sex-specific
changes to the effects of running on the aging brain

uated separately as ADRD risk varies between the sexes, with higher
risk in women compared to men.57,58 Sex is typically used as a covariate in human studies, but our data show that APOE genotype and sex

Unbiased transcriptional profiling was used to capture molecular

interact across multiple domains. Additionally, there is a lack of con-

effects across APOE genotype and activities (12 groups per brain

sideration that odds ratios are sex-specific when assessing clinical tri-

region, Figure 5A; see Methods). PCA revealed brain region (PC1,

als, obfuscating the effects of sex. Our data suggest APOE genotype for

65%) and sex (PC2, 20%) were the primary drivers of variance, sug-

each sex should be considered for studies assessing exercise interven-

gesting APOE genotype and running are not exerting strong effects

tions to reduce risk for dementia and more broadly any diseases for

(Figure 5B). Therefore, to determine subtle effects of APOE geno-

which APOE genotype has been associated.

type and running, linear modeling was used for male or female cor-

While the brain has been shown to be plastic throughout adult-

tex or hippocampus samples separately (four linear models in total;

hood, environmental influences can exert a greater effect on a younger

Figure 5C). Supporting the PCA data, linear modeling revealed fewer

brain compared to an older brain,19,23,38,59–62 prompting us to study

than 200 significant genes in females for the cortex and hippocam-

the effects of APOE genotype and running from early age to midlife.

pus, and fewer than 800 genes in males (Figure 5D–G). These num-

We assessed 12-month-old mice to understand the effect of APOE

bers align with published data from human studies but are somewhat

and running up until midlife, likening our findings to prodromal stud-

fewer than previous mouse studies (Figure S12). Several significant

ies in humans.63,64 APOE genotype-specific effects may also be appar-

genes including Ephx1 (main effect: APOE ε3/ε4), Ctsf (main effect: APOE

ent at older ages so studying later timepoints in the mouse, even begin-

ε4/ε4), C3 (interaction APOE ε3/ε4:Run), and Cav3 (interaction APOE

ning running at midlife, would be informative. This would relate closely

ε4/ε4:Run) are known to function in lipid homeostasis, neuroinflamma-

to some human clinical trials that conduct studies on older, affected

tion, and membrane integrity, key processes implicated in ADRD risk

human populations (i.e., nursing home/hospice patients).65–67 Addi-

(Figure 5H).

tionally, it is unknown if exercise affects APOE production in the brain

Through Gene Set Enrichment Analysis (GSEA), for the female cor-

and periphery. While APOE production is assumed to be stable, it is

tex, GO terms showed positive normalized enrichment scores (NES) for

possible that expression is directly or indirectly affected by exercise-

the main effects (running, APOE ε3/ε4, and APOE ε4/ε4), but negative

related changes, such as BDNF, FNDC5/Irisin, and other systemic fac-

NES for the interactive terms (APOE ε3/ε4:Run, APOE ε4/ε4:Run) for

tors that promote neuroprotection. However, one human study sug-

vascular and synaptic/neuronal functions (Figure 6A–C)). Also, inter-

gested that exercise paradigms helped preserve cognition in APOE ε4

estingly, in males, there were few significantly enriched GO terms

carriers more effectively over APOE ε3 controls suggesting APOE ε4

for APOE ε3/ε4, suggesting in males, but not females, the APOE ε3/ε4

carriers to be more responsive to exercise-induced myokines; however,

genotype exerts little to no effect compared to the APOE ε3/ε3 geno-

the APOE levels were not tested.68 It is still necessary to carry out fur-

type on genes associated with vascular integrity–related processes

ther clinical analyses, and while many ADRD studies include exercise as

(Figure 6D). Transcriptional profiling supplemented our peripheral

an intervention, the mechanisms by which APOE ε4 and exercise inter-

findings, determining that running and APOE genotype interact in sex-

act to affect amyloid beta deposition, tau tangle accumulation, neuroin-

specific ways to influence mechanisms involved in dementia-relevant

flammation, vascular disruption, and other important ADRD patholo-

biological processes.

gies are still to be performed.69–71

presented as mean ± standard error of the mean, two-way analysis of variance performed for APOE genotype (significant marked above “Sed”
column, indicating an effect of APOE genotype), Running (significance marked above “Run” column, indicating an effect of running), and the
interaction between APOE genotype:running (significance marked to the right of the graph). Bonferroni’s multiple comparisons performed for
within genotype running effects (significance marked in smaller stars directly to the right of the run column, within graph limits, in the color of the
genotype). *P < .05, **P < .01, ***P < .001, ****P < .0001
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(B)

(D)

(E)

(F)

(G)

(H)

F I G U R E 5 Transcriptional profiling reveals subtle changes due to apolipoprotein E (APOE) genotype and running in the cortex and
hippocampus. A, Diagram of the cortical and hippocampal regions of the brain taken for transcriptional profiling (n = 6 per sex/genotype/activity).
B, Principal components analysis revealed clear separations between brain regions (cortex and hippocampus, 65% variance explained), as well as
by sex (female and male, 20% of variance explained). C, Schematic of the computational analysis approach; first RNA-seq was separated by brain
region, next separated again by sex. Four linear models were run to examine gene expression as it varies with running, APOE genotype, and the
interaction between APOE genotype:running. β-value is the association of the gene with the factor tested—positive β-value indicates a positive
correlation, negative β-value indicates a negative correlation. D-G, Number of significant genes (false discovery rate corrected) for female cortex
(D), female hippocampus (E), male cortex (F), and male hippocampus (G). H, Example of a significant gene for each of the main effects and interactive
effects: Meox1 (Hippocampus, Male), Ephx1 (Hippocampus, Male), Ctsf (Hippocampus, Female), C3 (Hippocampus, Male), Cav3 (Cortex, Male)
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(A)

(B)

(C)

(D)

F I G U R E 6 Gene set enrichment analysis (GSEA) predicts apolipoprotein E (APOE) genotype and running interact to mitigate main effects. A,
Schematic of computational approach; β-values from linear models were passed through GSEA for gene ranking, GSEA plots were used to visualize
results and main effects of running, APOE genotype, and APOE genotype:running were interpreted per Gene Ontology (GO) term. B, GSEA plots for
“Collagen Fibril Organization” in the female cortex. Main effects of running and APOE ε3/ε4, and APOE ε4/ε4 all show positive enrichment scores,
while the interactions, APOE ε3/ε4:run and APOE ε4/ε4:run reveal negative enrichment scores. C, In the female cortex data GO terms that fit the
pattern shown in (B), colored by normalized enrichment score (NES), are represented specifically vascular integrity, mitochondrial metabolism, and
synaptic/neuronal health. D, The pattern observed in male cortex was different than that seen in female cortex (B,C) with APOE ε3/ε4 appearing
more similar to APOE ε3/ε3 (indicated by gray boxes) for enrichment terms grouped as cell motility, mitochondrial metabolism, vascular integrity,
and immune system response
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Transcriptomic approaches have revolutionized our understanding

The APOE ε4 allele emerged as our early hominin ancestors adapted

of ADRDs and have therefore become a hypothesis-generating tool

to changes in habitat and food availability to include more aerobic exer-

for identifying the molecular pathways impacted by genetic and envi-

cise such as running.75 The APOE ε4 allele was beneficial for storage

ronmental risk factors. Therefore, we used transcriptional profiling to

of fats, increasing cholesterol. While the APOE ε4 conferred longer

identify interactions between APOE genotype and running. Our data

lifespan 200,000 years ago, the diet and exercise of an individual was

revealed a reversal of NES direction from the main effects and the

drastically different.75 Currently, Western culture sees some of the

interaction of APOE genotype and running. This was unexpected, as we

highest rates of ADRD, due to the interaction between APOE ε4 and

saw similar patterns of positive (or negative) enrichment for (1) run-

our environment, and as we show, running. This work supports that

ning compared to sedentary, (2) APOE ε3/ε4 compared to APOE ε3/ε3,

APOE ε4 interacts with running in a genotype- and sex-specific man-

and (3) APOE ε4/ε4 compared to APOE ε3/ε3. These results contradict

ner to influence peripheral and central risk factors for diseases such as

the assumption that running would have the opposite effect on the

ADRDs.

brain as APOE ε4, particularly when considering each of these terms
collectively (vascular, immune, mitochondrial, neuronal/synaptic). We
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